Applied Genetic Technologies Corp.
06/17/2021 | Press release | Distributed by Public on 06/17/2021 16:55
Initial Insider Trading Report (SEC Filing - 3)
SEC FORM 3SEC Form 3
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
|
2. Date of Event Requiring Statement (Month/Day/Year) 06/09/2021 |
3. Issuer Name and Ticker or Trading Symbol APPLIED GENETIC TECHNOLOGIES CORP [ AGTC] |
||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
|
5. If Amendment, Date of Original Filed (Month/Day/Year) |
|||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
| Table I - Non-Derivative Securities Beneficially Owned | |||
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 25,000(1) | D |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) |
||||||
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | |
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | |||
| Stock Option (right to buy) | (2) | 03/30/2030 | Common Stock | 50,000 | 3.28 | D |
| Stock Option (right to buy) | (3) | 08/05/2030 | Common Stock | 30,000 | 5.5 | D |
| Explanation of Responses: |
| 1. Represents a grant of restricted stock units ('RSUs') under the Applied Genetic Technologies Corporation ('AGTC') 2013 Equity and Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of AGTC common stock. The RSUs vest in two equal annual installments, with 50% vesting on May 26, 2022 and the remaining 50% vesting on May 26, 2023, subject to the Reporting Person's continued employment with or performance of services for the Company as of each vesting date. |
| 2. The option was granted on March 30, 2020. The option became exercisable for 25% of the underlying shares on the first anniversary of the grant date, and thereafter became and continues to become, as applicable, exercisable for the remaining underlying shares in equal monthly installments over three years, resulting in the option being exercisable for 100% of the underlying shares on the fourth anniversary of the grant date. |
| 3. The option was granted on August 5, 2020. The option became and continues to become exercisable in equal monthly installments over four years from the date of grant. |
| Remarks: |
| Exhibit 24 Power of Attorney filed herewith. |
| /s/ Stacie Aarestad, Attorney-in-fact | 06/17/2021 |
| ** Signature of Reporting Person | Date |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | |
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | |
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |